The genetics testing company 23andMe licensed the rights to a drug it developed in-house to a Spanish pharmaceutical company, Bloomberg reported. This is the first time that the company has directly sold a product it created using the genetic information collected from users.
23andMe has already shared genetic data with pharmaceutical companies. GlaxoSmithKline has the exclusive rights to use its data for drug development, and purchased a $300 million stake in the company in 2018. But those drug companies use the company’s data to create their own drugs. In this case, 23andMe identified a drug candidate and conducted animal studies on that drug internally before selling it. The Spanish company, Almirall, will take the product through…
Adam E. WilliamsAccount Manager with 20 years experience in Information Technology, Logistics, and Games Industries. Client-centric professional compelled to achieve greater win-win successes through focused solution sales. Striving to attain broader knowledge for greater achievements through continuous learning. Enthusiastic about providing proven customer service, sales, and communication to foster strong business relationships for mutual growth and benefit. I would love to share how my Sales, Business Development, Operations and Account Management experience and education can be a key asset to the success of your team or project.
I have enjoyed a varied career over that time, which has given me a unique perspective and insight into business. More so, as an entrepreneur in the past, I have learned some powerful lessons on what to do to succeed as well as what not to do.
I am a proven producer with a track record of increasing success and I have found that my success comes from continuous learning with a focus on the Pillars of Integrity, Creativity, and Perseverance. Let me bring that to bear for you in your project or team!